Patents by Inventor Milos Stastny

Milos Stastny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5196349
    Abstract: Immunoassays for measuring thyroid hormones such as thyroxine(T.sub.4) and triiodothyronine(T.sub.3) are carried out by incubating a serum sample with either (a) unlabeled thyroglobulin and a labeled antibody to a thyroid hormone or to thyroxine binding globulin(TBG), or (B) labeled thyrogloublin and an unlabeled antibody to a thyroid hormone. The thyroglobulin may be immobilized on an insoluble carrier and the immobilized thyroglobulin is preferably modified by succinylation with succinic anhydride. Whole thyroglobulin can be used or the thyroglobulin can be fragmented into smaller peptides prior to use provided the peptides contain at least one T.sub.3 or T.sub.4 residue per peptide. Preferably, the antibody is a monocional antibody and labeling is with an acridinium ester.
    Type: Grant
    Filed: October 17, 1990
    Date of Patent: March 23, 1993
    Assignee: Ciba Cornign Diagnostics Corp.
    Inventors: Uri Piran, Milos Stastny
  • Patent number: 4956299
    Abstract: The present invention relates to a novel method for stabilizing aqueous solutions of serum complement for extended periods of time and the resultant stabilized complement solutions. More particularly, morphilino buffering compounds and tris-hydroxymethyl buffering compounds have been used to make aqueous buffers with a pH between about 6.5 and 8.5 and a concentration of greater than 0.01M. These buffers have been found to extend the normal life of complement solutions to unexpectedly longer periods.
    Type: Grant
    Filed: December 31, 1986
    Date of Patent: September 11, 1990
    Assignee: Ciba Corning Diagnostics Corp.
    Inventors: Uri Piran, Milos Stastny, Laura S. Uretsky
  • Patent number: 4222836
    Abstract: Glycosylated hemoglobins are separated from other hemoglobin variants by electrochromatography on an agar gel at an acidic pH which utilizes:A. an agar gel having a wet thickness of from about 0.1 to about 0.5 mm.,B. a citrate gel buffer having a citrate concentration of from about 0.02 to about 0.05 M and a pH of from about 5.8 to about 6.8,C. a citrate well buffer having a citrate concentration of from about 0.05 to about 0.1 M and a pH from about 6.0 to about 6.5, andD. a potential of from about 25 to about 100 volts.
    Type: Grant
    Filed: June 1, 1979
    Date of Patent: September 16, 1980
    Assignee: Corning Glass Works
    Inventors: Robert J. Kerr, Milos Stastny